Giancarlo C. Viberti
#157,358
Most Influential Person Now
Giancarlo C. Viberti's AcademicInfluence.com Rankings
Giancarlo C. Vibertimedical Degrees
Medical
#3103
World Rank
#3558
Historical Rank
Nephrology
#20
World Rank
#20
Historical Rank
Giancarlo C. Vibertiphilosophy Degrees
Philosophy
#8937
World Rank
#12418
Historical Rank
Logic
#5944
World Rank
#7408
Historical Rank
Download Badge
Medical Philosophy
Giancarlo C. Viberti's Degrees
- Doctorate Medicine University of Turin
- PhD Nephrology University of Turin
Why Is Giancarlo C. Viberti Influential?
(Suggest an Edit or Addition)Giancarlo C. Viberti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS (1982) (1723)
- Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus: A Blood Pressure–Independent Effect (2002) (820)
- Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. (2011) (743)
- Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria (1994) (576)
- Microalbuminuria Predicts Mortality in Noninsulin‐dependent Diabetes (1984) (574)
- Prevention of diabetic renal disease with special reference to microalbuminuria (1995) (567)
- Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. (1994) (435)
- Avosentan for overt diabetic nephropathy. (2010) (423)
- Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes. (1979) (342)
- Podocyte number in normotensive type 1 diabetic patients with albuminuria. (2002) (295)
- Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes (1983) (271)
- A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes. (2002) (249)
- Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. (1993) (222)
- The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy. (2014) (217)
- Prevalence and concomitants of glucose intolerance in European obese children and adolescents. (2003) (207)
- Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes (2006) (187)
- Pathogenesis of diabetic nephropathy. (2001) (169)
- Single-blind studies of the effects of improved periodontal health on metabolic control in type 1 diabetes mellitus. (1995) (162)
- continuous Subcutaneous Insulin Infusion in the Treatment of Diabetes Mellitus (1980) (159)
- Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER (2003) (155)
- Microalbuminuria and cardiovascular risk. (2004) (154)
- Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus (2007) (147)
- Valsartan Improves Arterial Stiffness in Type 2 Diabetes Independently of Blood Pressure Lowering (2008) (143)
- Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the Kroc Collaborative Study. The Kroc Collaborative Study Group. (1988) (143)
- Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. (2007) (142)
- Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? (1993) (141)
- Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. (1982) (136)
- Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. (2005) (135)
- Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. (2005) (131)
- Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors (2006) (128)
- Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. (1992) (111)
- Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study (2006) (104)
- Glycaemia, arterial pressure and micro-albuminuria in Type 1 (insulin-dependent) diabetes mellitus (1984) (103)
- Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice (2008) (103)
- Effect of various diuretic treatments on rosiglitazone-induced fluid retention. (2006) (102)
- Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. (2000) (100)
- Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. (2000) (100)
- Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism. (2007) (97)
- GLUT-1 Overexpression: Link Between Hemodynamic and Metabolic Factors in Glomerular Injury? (2003) (96)
- Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. (2005) (95)
- Correction of Exercise-induced Microalbuminuria in Insulin-dependent Diabetics After 3 Weeks of Subcutaneous Insulin Infusion (1981) (83)
- Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria (1993) (80)
- Mechanical forces and TGFbeta1 reduce podocyte adhesion through alpha3beta1 integrin downregulation. (2009) (80)
- Serum lipids and the progression of nephropathy in type 1 diabetes. (2006) (79)
- Vascular responsiveness and cation exchange in insulin-dependent diabetes. (1991) (76)
- Multiple Lipoprotein Abnormalities in Type I Diabetic Patients With Renal Disease (1996) (72)
- Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria. (2013) (69)
- A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe (2006) (69)
- High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria (1997) (68)
- Sodium‐Lithium Countertransport and Cardiorenal Abnormalities in Essential Hypertension (1991) (63)
- Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes (2006) (63)
- Proteinuria in diabetes: bystander or pathway to cardiorenal disease? (2010) (61)
- Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study (2009) (59)
- Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans (2006) (54)
- Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. (1983) (53)
- No Change in Glomerular Heparan Sulfate Structure in Early Human and Experimental Diabetic Nephropathy* (2006) (50)
- Neovascularization at the vascular pole region in diabetic glomerulopathy. (1999) (48)
- Glomerular response to hyperglycemia in human diabetic nephropathy. (1990) (47)
- Renal Response to Restricted Protein Intake in Diabetic Nephropathy (1988) (47)
- Does microalbuminuria predict diabetic nephropathy? (2002) (46)
- Detection of Potentially Reversible Diabetic Albuminuria: A Three-drop Agglutination Test for Urinary Albumin at Low Concentration (1982) (46)
- MICROALBUMINURIA AS PREDICTOR OF NEPHROPATHY IN DIABETICS (1982) (45)
- GLUCOSE-INDUCED HYPERKALÆMIA: A HAZARD FOR DIABETICS? (1978) (43)
- Progression of subclinical polyneuropathy in young patients with Type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications) (1986) (43)
- Eight-Month Correction of Hyperglycemia in Insulin-dependent Diabetes Mellitus Is Associated with a Significant and Sustained Reduction of Urinary Albumin Excretion Rates in Patients with Microalbuminuria (1985) (42)
- St Vincent Declaration, 1994: Guidelines for the Prevention of Diabetic Renal Failure (1994) (42)
- The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) Observational Follow‐Up Study: Benefits of RAS Blockade With Olmesartan Treatment Are Sustained After Study Discontinuation (2014) (41)
- Diabetic nephropathy: etiology and prevention. (1988) (39)
- A glycemic threshold for diabetic complications? (1995) (38)
- Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal. (1993) (38)
- Circulating Vascular Progenitor Cells in Patients With Type 1 Diabetes and Microalbuminuria (2010) (37)
- Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion. (1981) (37)
- Effects of high dose aleglitazar on renal function in patients with type 2 diabetes. (2011) (36)
- Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. (1997) (36)
- Microalbuminuria as prediction of nephropathy in diabetics. (1982) (35)
- Targeting albumin excretion rate in the treatment of the hypertensive diabetic patient with renal disease. (2005) (34)
- Comparison of blood pressure measurement methods in adult diabetics (1997) (33)
- Effect of the antihistaminic agents meclastine and dexchlorpheniramine on the response of human growth hormone to arginine infusion and insulin hypoglycemia. (1976) (33)
- Glomerular hyperfiltration as a risk factor for diabetic nephropathy: Five-year report of a prospective study (2004) (33)
- Prevention of microalbuminuria in patients with type 2 diabetes and hypertension (2012) (33)
- Selective and extremely long inhibition of prolactin release in man by 1-ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta- carbonyl)-urea-diphosphate (FCE 21336). (1987) (33)
- Systemic Inflammation Precedes Microalbuminuria in Diabetes (2019) (31)
- Recent advances in understanding mechanisms and natural history of diabetic renal disease. (1988) (30)
- Losartan reduces the burden and cost of ESRD: public health implications from the RENAAL study for the European Union. (2002) (30)
- Protein intake and blood glucose as modulators of GFR in hyperfiltering diabetic patients. (1992) (30)
- Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics. (1980) (29)
- Glomerular volume and the glomerular vascular pole area in patients with insulin-dependent diabetes mellitus (1997) (28)
- Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects. (1980) (28)
- Modelling and costing the consequences of using an ACE inhibitor to slow the progression of renal failure in type I diabetic patients. (1997) (27)
- Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study (2014) (26)
- Predisposition to essential hypertension and the development of diabetic nephropathy. (1992) (26)
- IGF-I induces vascular endothelial growth factor in human mesangial cells via a Src-dependent mechanism. (2003) (25)
- Thiazolidinediones-benefits on microvascular complications of type 2 diabetes. (2005) (25)
- Safety of continuous subcutaneous insulin infusion: Metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion (1982) (24)
- Glomerular filtration rate gfr extracellular fluid volume ecv and atrial natriuretic factor anf in insulin dependent diabetics (1988) (24)
- Lipolytic effect of intra-arterial injection of glucagon in man. (1971) (24)
- —to: Ong KK, Petry CJ, Emmett PM et al.; ALSPAC study team (2004) Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47:1064–1070 (2004) (24)
- Early functional and morphologic vascular renal consequences of the diabetic state (1980) (24)
- The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression. (2002) (22)
- Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy. (2006) (21)
- Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa. (2000) (21)
- Early functional and morphological changes in diabetic nephropathy. (1979) (21)
- Antihypertensive effects of double the maximum dose of valsartan in African–American patients with type 2 diabetes mellitus and albuminuria (2010) (20)
- The need for tighter control of cardiovascular risk factors in diabetic patients. (2003) (19)
- Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine. (1977) (19)
- Glucose-induced hyperkalaemia: A hazard for diabetics? (1978) (19)
- Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy. (1993) (19)
- The Decorin Gene 179 Allelic Variant Is Associated with a Slower Progression of Renal Disease in Patients with Type 1 Diabetes (2002) (18)
- Report on renal disease in diabetes. (1996) (18)
- Mechanical forces and TGF β 1 reduce podocyte adhesion through α 3 β 1 integrin downregulation (2009) (18)
- O-6: Microalbuminuria reduction with valsartan (2001) (18)
- A pragmatic lifestyle modification programme reduces the incidence of predictors of cardio-metabolic disease and dysglycaemia in a young healthy urban South Asian population: a randomised controlled trial (2017) (17)
- Plasma Insulin and C-Peptide After Subcutaneous and Intravenous Administration of Human Insulin (recombinant DNA) and Purified Porcine Insulin in Healthy Men (1982) (16)
- Dietary Protein and the Diabetic Kidney (1987) (16)
- DIABRISK - SL Prevention of cardio-metabolic disease with life style modification in young urban Sri Lankan's - study protocol for a randomized controlled trial (2011) (15)
- Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy (2008) (15)
- High Prevalence of Cardio-Metabolic Risk Factors in a Young Urban Sri-Lankan Population (2012) (15)
- Renal functional reserve in subjects with diabetes mellitus. (1995) (15)
- Diabetes mellitus: a major challenge in transplantation. (2001) (15)
- Biosynthetic Human Insulin: Effect in Healthy Men on Plasma Glucose and Non-Esterified Fatty Acids in Comparison with Highly Purified Pork Insulin (1981) (15)
- Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years (2017) (15)
- Predictors for the development of microalbuminuria and interaction with renal function (2017) (15)
- Regression of albuminuria: latest evidence for a new approach (2003) (15)
- Aspects of Continuous Subcutaneous Insulin Infusion (CSII) in Diabetes (1981) (14)
- Predicting diabetic nephropathy. (1984) (14)
- Interventions based on microalbuminuria screening and low-protein diet in the treatment of kidney disease of diabetes mellitus. (1989) (14)
- Hypertension and microalbuminuria: Risk factors for cardiovascular disease in diabetes (2005) (14)
- Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Prevents Albuminuria but Not Glomerulosclerosis in Experimental Diabetes (2010) (14)
- Risk factors for renal and cardiovascular disease in diabetic patients. (1991) (13)
- Metabolic effects of physical exercise in insulin-dependent diabetics controlled by continuous subcutaneous insulin infusion or conventional injection therapy. (1984) (13)
- Does "afternoon diabetes" predict diabetes? (1978) (13)
- A quantitative ultrastructural study of juxtaglomerular arterioles in IDDM patients with micro- and normoalbuminuria (1995) (13)
- Bedside estimation of microalbuminuria. (1985) (12)
- Hypertension and microalbuminuria as predictors of diabetic nephropathy. (1989) (12)
- Why do we have to invoke genetic susceptibility for diabetic nephropathy? (1999) (12)
- Effect of spironolactone and amiloride on thiazolidinedione-induced fluid retention in South Indian patients with type 2 diabetes. (2013) (11)
- PREVENTION OF MICROALBUMINURIA IN TYPE 2 DIABETES (ROADMAP TRIAL): 6A.02 (2010) (11)
- Low-protein diet and progression of diabetic kidney disease. (1988) (11)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Role of insulin-like growth factor (IGF)-1 in the modulation of renal haemodynamics in Type I diabetic patients (2000) (10)
- Natural history and pathogenesis of diabetic nephropathy. (1991) (10)
- Proteinuria and diabetic control in insulin-dependent diabetes mellitus. (1981) (10)
- Genetic factors and susceptibility to diabetic nephropathy. (1988) (9)
- Should we screen for microalbuminuria in essential hypertension? (1999) (9)
- Kidney size and glomerular filtration rate in type 1 (insulin-dependent) diabetes mellitus revisited (1983) (8)
- MICROALBUMINURIA AND DIABETES (1983) (8)
- Impaired glucose tolerance in obese children and adolescents. (2002) (7)
- Preventive approach to diabetic kidney disease. (1988) (7)
- TGF-beta 1 and mechanical stretch reduce murine podocyte adhesion to extracellular matrix substrate and modulate beta 1 integrin expression/maturation in vitro (2005) (6)
- Commentary: the birth of microalbuminuria: a milestone in the history of medicine. (2014) (6)
- 2. Measurement of GFR by 51Cr-EDTA plasma clearance: the correction for the one-pool assumption (1993) (6)
- Cardiovascular risk in diabetic kidney disease: a model of chronic renal disease. (2005) (6)
- Obesity and the metabolic syndrome in children and adolescents. (2004) (6)
- Permissive role of hypertension in the development of proteinuria and progression of renal disease in insulin‐dependent diabetic patients (1997) (6)
- Evaluation of Rosiglitazone Administration on Cardiovascular Function in Severe Obesity (2008) (5)
- Microalbuminuria in diabetes: Data dispersion: Author's reply (1993) (5)
- Introduction: Symposium on the Progress in Diabetic Nephropathy (1992) (5)
- The effect of dietary changes on distinct components of the metabolic syndrome in a young Sri Lankan population at high risk of CVD (2016) (4)
- Reduction of Microalbuminuria and Glomerular Filtration Rate by Dietary Protein Restriction in Insulin Dependent Diabetics: An Effect Independent of Blood Glucose Control and Arterial Pressure Changes (1986) (4)
- Effect of metergoline, a powerful and long-acting antiserotoninergic agent, on insulin secretion in normal subjects and in patients with chemical diabetes (1975) (4)
- Early closure of European Pimagedine trial. Steering Committee. Safety Committee. (1997) (4)
- Cigarette smoking and diabetic nephropathy. (2000) (4)
- Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system. (1979) (4)
- Infusion-pump treatment of diabetes mellitus. (1979) (4)
- Early Markers of Diabetic Nephropathy: A Road to Prevention (1984) (4)
- Determinants of response to insulin therapy following failure of oral agents in type 2 diabetes. (2005) (4)
- Improvements in stage of change correlate to changes in dietary intake and clinical outcomes in a 5-year lifestyle intervention in young high-risk Sri Lankans. (2016) (4)
- Strategies for the prevention of diabetic kidney disease: early antihypertensive treatment or improved glycemic control? (1994) (4)
- Podocyte-Specific Induced Overexpression of Angiopoietin-2 Causes Proteinuria and Apoptosis of Glomerular Endothelia (2007) (4)
- Risk of nephropathy in diabetes mellitus: problems of methodology and terminology (1985) (4)
- Sodium-Hydrogen Antiport, Cell Function and Susceptibility to Diabetic Nephropathy (1996) (4)
- Growth Hormone Response to Arginine in Normal Subjects and in Patients with Chemical Diabetes and Effect of Clofibrate and of Metergoline (1977) (4)
- Abstract 426: The Diovan Reduction Of Proteinutria (Drop) Study: Albuminuria Response to High-Doses Of Valsartan in Type 2 Diabetes Mellitus (2006) (3)
- Office and ambulatory pulse pressure—association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study) (2011) (3)
- Protein restriction, blood pressure and the progression of diabetic nephropathy. (1988) (3)
- β-Adrenoreceptor Blockade and Diabetes Mellitus: Effect of Oxprenolol and Metoprolol on the Metabolic, Cardiovascular and Hormonal Response to Insulin-Induced Hypoglycaemia in Normal Subjects (1980) (3)
- OR-49: Treatment based on a low dose combination of perindopril and indapamide reduces albuminuria more effectively than enalapril in hypertensive type 2 diabetic patients (2002) (3)
- Intermittent clinical proteinuria and renal function in diabetes (1986) (3)
- Antibodies to human albumin epitopes in Type 1 (insulin-dependent) diabetes mellitus (1988) (3)
- BEDSIDE ESTIMATION OF MICROALBUMINURIA (1986) (3)
- Comment on: Boden et al. (2007) Combined Use of Rosiglitazone and Fenofibrate in Patients with Type 2 Diabetes: Prevention of Fluid Retention: Diabetes 56:248–255 (2007) (3)
- Prevalence of microalbuminuria in recently diagnosed Type 2 diabetes mellitus and its relationship to non-traditional risk factors: observations from the ADOPT study (2003) (3)
- Prevalence of hypertension in Type 1 (insulin-dependent) diabetes mellitus (2004) (3)
- Searching for new coronary heart disease risk factors. (2000) (3)
- Is it possible to predict diabetic kidney disease? (2000) (3)
- Low-protein diet and progression of renal disease in diabetic nephropathy (1990) (3)
- The kidney in Type 2 (non-insulin-dependent) diabetes mellitus (1993) (2)
- [The need for strict control of cardiovascular risk factors in type 2 diabetic patients]. (2002) (2)
- Screening to prevent renal failure in diabetic patients (1996) (2)
- Predictors of rosiglitazone induced fluid retention (2005) (2)
- The structure of glomeruli and juxtaglomerular arterioles in the early phase of diabetic nephropathy--relationship between progression and metabolic control. (1996) (2)
- EFFECTS OF ALEGLITAZAR ON CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH STAGE 3 CHRONIC KIDNEY DISEASE AND TYPE II DIABETES (2013) (2)
- Effect of intensive treatment in insulin dependent diabetes mellitus with microalbuminuria. (1996) (2)
- Rosiglitazone prevents stretch-induced MCP-1 production in human mesangial cells (2002) (2)
- Microalbuminuria and Cardiovascular Disease (2000) (2)
- Fluorescein angiography in borderline diabetics. (1979) (2)
- Rosiglitazone prevents stretch-induced monocytes recruitment by inhibiting the NFkB-MCP1 pathway in human mesangial cells. (2003) (2)
- GLUT1 is upregulated in glomerular hypertension: Possible role in the pathophysiology of diabetic glomerulopathy (2001) (2)
- Pathophysiology of renal and vascular disorders in insulin-dependent diabetes. (1993) (2)
- [The kidney as a target organ in diabetic patients with arterial hypertension]. (2003) (1)
- Mechanical stretch induces reduction in alpha3 beta1 integrins in Glomerular Epithelial Cells in vitro (2001) (1)
- Treatment of the pre-azotaemic phases of kidney disease in diabetes. (1995) (1)
- OP49 A LOW COST PRIMARY PREVENTION TOOL: EFFECTS OF NON PHARMACOLOGICAL LIFESTYLE MODIFICATION IN PREVENTION OF TYPE 2 DIABETES MELLITUS IN YOUNG URBAN SRI LANKAN – “DIABRISK-SL” (2014) (1)
- The link between mechanical stretch and glucose metabolism--a conceptual advance in understanding diabetic (and non diabetic?) renal disease. (2006) (1)
- ROADMAP OBSERVATIONAL FOLLOW-UP STUDY: BENEFITS OF RAAS BLOCKADE WITH OLMESARTAN TREATMENT ARE SUSTAINED AFTER STUDY DISCONTINUATION (2014) (1)
- Natural history and treatment of diabetic nephropathy. (1989) (1)
- Effect of ageing on insulin and growth hormone response to glucose and arginine in normal subjects (1974) (1)
- Recent advance in the treatment of diabetic nephropathy: low-protein diet. (1991) (1)
- Management of asymptomatic diabetic kidney disease. The interface between clinical research and clinical practice (1985) (1)
- Diabetic nephropathy: pathophysiology, clinical course and susceptibility. (1989) (1)
- Treatment and Prevention of Diabetic Nephropathy in Caucasian and Asian Patients (2006) (1)
- Insulin growth factor-1 induces vascular endothelial growth factor protein secretion via a Src-dependent mechanism in human mesangial cells (2002) (1)
- Diabetes: Excess mortality in well-controlled T1DM without renal disease (2015) (1)
- Lack of evidence for the 1484insG variant at the 3'-UTR of the protein tyrosine phosphatase 1B (PTP1B) gene as a genetic determinant of diabetic nephropathy development in type 1 diabetic patients. (2004) (1)
- β-Adrenoreceptor Blockade and Diabetes Mellitus: Effect of Oxprenolol and Metoprolol on the Metabolic, Cardiovascular and Hormonal Response to Insulin-Induced Hypoglycaemia in Insulin-Dependent Diabetic Patients (1980) (1)
- PEDIATRIC HIGHLIGHT Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors (2006) (1)
- Effect of metergoline, a specific serotonin antagonist, on human growth hormone response to arginine and L-dopa. (1976) (1)
- Mechanism of hypertension-mediated end-organ damage in diabetes (2003) (1)
- Concomitans of ambulatory blood pressure parameters in obese children (2004) (0)
- Losartan reduces the burden of ESRD: public health implications from the RENAAL study for the European Union (2002) (0)
- Olmesartan, Microalbuminuria, and Type 2 Diabetes REPLY (2011) (0)
- Cigarette smoking and diabetic nephropathy. [Review] [41 refs] (2000) (0)
- VEGF receptors and expressed in vitro and ex-vivo (2000) (0)
- Treatment of the fluids retention connected to the rosiglitazone (2006) (0)
- Secular trend of glucose intolerance in obese Caucasian children in Italy. (2003) (0)
- Predictors of microvascular and macrovascular disease in Type 1 diabetes. (2000) (0)
- "Podocyte specific angiopoietin-2 overexpression results in endothelial cell apoptosis and proteinuria" (2006) (0)
- Cigarette Smoking and the Kidney (2000) (0)
- Vascular responses and ion exchange in diabetes: Authors' reply (1992) (0)
- Angiotensin II receptor expression and function in human islets of Langerhans (2003) (0)
- Inducible overexpression of angiopoietin-1 and angiopoietin-2 in the glomeruli of adult transgenic mice via the tetracycline regulatable system (2005) (0)
- Hypertension and the renal vascular complications of diabetes: a structural basis to guide management. (1994) (0)
- Endothelial progenitor cells (CD34+/KDR+) are reduced in Type 1 diabetic patients with microalbuminuria (2007) (0)
- Lack of evidence for the 1484insG variant at 3 ' UTR of the PTP1B gene as a genetic determinant of risk for kidney disease in 1 Type diabetic patients (2002) (0)
- Microvascular and macrovascular risk factors in type 1 diabetes. (2002) (0)
- Inhibitory effect of clofibrate on arginine-induced insulin secretion in chemical diabetes (1976) (0)
- P-172: Cost-effectiveness of renoprotection in diabetic patients with an angiotensin II receptor antagonist and a calcium channel blocker: economic analysis of the marval trial (2003) (0)
- P.64 Active Vitamin D Treatment Does Not Improve Arterial Stiffness and Markers of Cardio-Renal Risk in Patients with Type 2 Diabetes and Stage 3 Chronic Kidney Disease: a Randomised Controlled Trial (2020) (0)
- Experimental pathology - 1 (2009) (0)
- PREVENTION OF MICROALBUMINURIA: EFFECT OF BASELINE UACR AND CHANGES IN THE EGFR ON OUTCOME (ROADMAP TRIAL): 7E.09 (2011) (0)
- High prevalence of cardiovascular disease risk factors, but inadequate risk factor interventions, in diabetic patients on dialysis or after renal transplantation. (2002) (0)
- Impaired glucose tolerance, insulin resistance and inflammatory markers in obese children. (2001) (0)
- Treatment based on a very low dose combination of perindopril and indapamide reduces albuminuria more effectively than enalapril in hypertensive Type 2 diabetic patients: the PREMIER study (2002) (0)
- Plasmapheresis with immunosuppressive therapy vs immunosuppressive therapy alone for rapidly progressive anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis (2004) (0)
- Osmotic and Electrolytic Changes during an Oral Glucose Tolerance Test in Diabetics (1978) (0)
- Accurate measurement of albuminuria at reduced cost. (2004) (0)
- Determinants of ambulatory blood pressure parameters in obese children (2004) (0)
- Diabetic cardiorenal syndrome: insights into its pathogenesis (1992) (0)
- Prevention of glomerular macrophages infiltration and renal MCP-1 expression by rosiglitazone in experimental diabetes (2005) (0)
- COST-EFFECTIVENESS OF VALSARTAN VERSUS AMLODIPINE TO TREAT MICROALBUMINURIA IN DIABETIC PATIENTS: ECONOMIC ANALYSIS OF THE MARVAL TRIAL (2004) (0)
- Inducible overexpression of angiopoietin-1 in podocytes results in albuminuria and foot process effacement in mice (2007) (0)
- HDL in CKD: How Good Is the "Good Cholesterol?" (2014) (0)
- Treatment of diabetic nephropathy: the role of strict glucose control (2003) (0)
- Mechanisms of diabetic renal and cardiovascular disease (1990) (0)
- Effects of aleglitazar on cardiovascular risk factors in patients with stage 3 chronic kidney disease and type 2 diabetes (2013) (0)
- Benefit of a treatment strategy based on a very low dose combination of perindopril and Indapamide in albuminuric hypertensive type 2 diabetics (2002) (0)
- Erratum to: Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study (2009) (0)
- High Prevalence of Ischaemic Heart Dtsease and Hyperlipidaemia in Non-Insulin-Dependent Diabetics with Microalbuminuria (1986) (0)
- Blood pressure even within the normal range is related to the change in renal structure and function in type I diabetic patients with albuminuria (2003) (0)
- Authors' reply (1996) (0)
- Urine collection from disposable nappies (1991) (0)
- Rosiglitazone inhibits human mesangial cell proliferation in vitro (2000) (0)
- Effects of valsartan on osteoprotegerin and receptor activator of nuclear factor kappa B ligand levels in patients with type 2 diabetes, systolic hypertension and microalbuminuria (2011) (0)
- Register of randomised trials (1999) (0)
- Free fatty acids reduce cell proliferation and enhance TGFbeta1 protein levels in human mesangial cells (2002) (0)
- No loss of glomerular heparan sulfate staining in patients with insulin dependent diabetes mellitus with microalbuminuria and early proteinuria (1999) (0)
- The effect of glycaemic control on the early abnormalities of the diabetic kidney. (1982) (0)
- Other Cardiovascular Risk Factors (2010) (0)
- c ontinuous Subcutaneous Insulin Infusion in the Treatment of Diabetes Mellitus (1980) (0)
- Stretch up-regulates VEGF in murine glomerular epithelial cells via a PKC-independent mechanism (2002) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Giancarlo C. Viberti?
Giancarlo C. Viberti is affiliated with the following schools:
